
Children with the rare cancer neuroblastoma often succumb to the disease despite aggressive treatment. But researchers have found that adding an experimental antibody to that treatment, right off the bat, may improve their outlook. Of 64 children treated with the antibody in a clinical trial, 74% were still alive and free of a recurrence three… read on > read on >